Anagenex
PrivateLast Round
Series A
Jun 8, 2022
Total Funding Raised
$44.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Anagenex is a biotechnology company that provides a drug discovery platform combining ultra-high-throughput biochemistry, DNA-encoded library technology, and machine learning to identify and optimize small molecule therapeutics for challenging medical targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anagenex Comparables
Compare Anagenex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terray Therapeutics | 81% | |
| Leash Bio | 81% | |
| Orogen Therapeutics | 80% |
Anagenex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 8, 2022 |
Anagenex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed, Series A |
| Air Street Capital | Seed, Series A |
| Lux Capital | Series A, Seed |
| Catalio Capital Management | Series A |
| Obvious Ventures | Seed, Series A |
| Menlo Ventures | Seed, Series A |
| Alloy Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 146% MoM, reaching 39.6K.
Anagenex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anagenex's valuation, stock price, and market status.
Is Anagenex a public or private company?
Anagenex is a private company.
What is the current stock price of Anagenex?
Anagenex is a private company, so its shares have no public market price. Caplight tracks Anagenex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anagenex worth (valuation)?
Valuation information for Anagenex is not publicly available.
Can I buy Anagenex stock?
Anagenex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anagenex's last funding round?
Anagenex's most recent funding round was Series A on June 8, 2022.
Who are the main investors in Anagenex?
Key investors in Anagenex include Lux Capital, Catalio Capital Management.
Will Anagenex IPO soon?
No public IPO plans have been announced for Anagenex.
How can I track Anagenex secondary market activity?
Caplight tracks bids, offers, and trades in Anagenex's shares on secondary markets.